Dr. Marcus Thorne is a Biomedical Research Scientist and Biotech Strategy Consultant with a PhD in Molecular Biology. He has 15 years of experience in drug discovery, lab automation, and navigating FDA regulatory pathways for new therapeutics.
Formerly a Principal Investigator at a major pharmaceutical research hub, Marcus specializes in the transition from bench to bedside, helping startups and academic labs optimize their operations. He has deep technical knowledge in genomics, CRISPR technology, and high-throughput screening. His content is tailored for lab managers, investors, and R&D directors, dissecting complex scientific innovations and the operational realities of running a reproducible, compliant laboratory. Marcus is dedicated to reducing the failure rate of pre-clinical studies through better data management and rigorous protocol design.